Charlyse Herrmann
Lab Head - Preformulation and Preclinal Galenics at Idorsia Pharmaceuticals Ltd - Allschwil, Basel Landschaft, CH
Charlyse Herrmann's Colleagues at Idorsia Pharmaceuticals Ltd
Andrew Weiss
Head of Investor Relations and Corporate Communications, Member of the Idorsia Leadership Team
Barbara Channer
Director Analytical Development Quality Control Drug Substance Clinical
Charlyse Herrmann's Contact Details
+41 58 844 10 10
Idorsia Pharmaceuticals Ltd
Charlyse Herrmann's Company Details
The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. See our LinkedIn community guidelines: https://www.idorsia.com/documents/com/policies-charters/idorsia-linkedin-community-guidelines.pdf Idorsia privacy policy: https://www.idorsia.com/system/legal-statements/privacy-policy